The HUNT lung-SNP model: genetic variants plus clinical variables improve lung cancer risk assessment over clinical models
Olav Toai Duc Nguyen(Norwegian University of Science and Technology), Oluf Dimitri Røe(Norwegian University of Science and Technology), Vincenzo Lagani(University of Crete), Ioannis Tsamardinos(University of Crete), Maria Markaki(University of Crete), Therese Haugdahl Nøst(UiT The Arctic University of Norway), Ioannis Fotopoulos(University of Crete)
Cited by 1
Related Papers
Applications of Machine Learning in Human Microbiome Studies: A Review on Feature Selection, Biomarker Identification, Disease Prediction and Treatment
|Frontiers in Microbiology|2021|390
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma
|Journal of Clinical Oncology|2018|229
Shortlasting, Unilateral Neuralgiform Headache Attacks with Conjunctival Injection, Tearing, Sweating, and Rhinorrhea
|Cephalalgia|1989|226
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
|European Respiratory Review|2015|188
Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins
|JAMA Oncology|2018|170